A1: Define the impact of shift work on autoimmunity and autoimmune diseases
Background. In our modern 24/7 society about 10 % of German employees work in night or rotating shifts. Resulting circadian disruption, mistimed sleep and emerging sleep disturbances can lead to low-grade systemic inflammation, loss of counter-regulatory anti-inflammatory control mechanisms, as well as impaired innate and adaptive immune defense against pathogens (Physiol Rev 99:1325; Proc Natl Acad Sci USA 113:E1402). Shift work is therefore a potential risk factor for diabetes, cardiovascular diseases, and cancer. Shift work is also associated with an increase in the prevalence of autoantibodies against thyreoperoxidase (Int J Immunopathol Pharmacol 19:31) and might promote autoimmune diseases like SLE (J Rheumatol 31:1928). First experiments confirm enhancing effects of sleep deprivation (Am J Physiol 291:R1527) or circadian disruption (Comp Med. 67:116) on disease progression in lupus-prone mice. The exact cellular and molecular mechanisms, however, remained elusive. We aim to fill this gap by analyzing inflammation and autoimmunity in shift workers and in mouse models.
Objectives. (i) Deep immunophenotyping of circadian disruption in humans and mice. (ii) Assess prevalence of defined autoantibodies in shift workers and in mouse models of circadian disruption. (iii) Circadian disruption in experimental models of autoimmune diseases.
Work program. To address the objectives (i) and (ii), a cohort of shift workers with day-time workers as controls (recruited from UKSH), and mice in which shift work is mimicked or mutant mice which lack clock genes will be deeply immunophenotyped (FACS analyses for immune cell repertoire, bead-based assay for chemo- and cytokines, whole-transcriptome analysis). This will be paralleled by determination of sleep parameters and autoantibodies. To functionally investigate the role of circadian disruption on the early development of autoimmune disease and to delineate potential mechanisms, the light-dark schedule will be manipulated in mice that develop spontaneous autoimmune disease (NZM2410 and BXD2).
![A1: Define the impact of shift work on autoimmunity and autoimmune diseases A1: Define the impact of shift work on autoimmunity and autoimmune diseases](/fileadmin/_processed_/7/1/csm_uzl_dachfenster_da28f23bf5.jpg)
- Projects
- 1st Generation
- A: Defining Autoimmune Pre-Disease
- A1: Define the impact of shift work on autoimmunity and autoimmune diseases
- A2: B cells as drivers towards clinical SLE manifestation
- A3: G protein-coupled receptors orchestrating granulocytes in pemphigoid diseases
- A4: Epitope-dependent autoantibody-mediated skin inflammation in pemphigoid disease
- A5: Chronic danger signaling as driver of autoimmunity in granulomatosis with polyangiitis
- A6: T cell memory differentiation in early autoimmune disease
- A7: CD4+ T cell receptor sequences during progression towards experimental pemphigoid.
- A8: The C5aR2 pathway as a checkpoint for B cell activation in autoimmunity.
- A9: Genetic and molecular similarity of autoimmune disease
- B: Targeting of Autoimmune Pre-Disease
- Associated projects
- MD projects
- Concluded Projects
- A: Defining Autoimmune Pre-Disease
- 2nd Generation
- 1st Generation